Ledisa vs Wegovy: An Honest Head-to-Head Comparison (2026)
The comparison at a glance
| Ledisa Botanical Patch | Wegovy (semaglutide) | |
|---|---|---|
| Category | Dietary supplement (botanical) | Prescription drug (GLP-1 receptor agonist) |
| Active ingredients | Berberine, cinnamon, green tea extract, apple cider vinegar, chromium | Semaglutide 2.4 mg |
| Delivery | Transdermal adhesive patch, daily | Subcutaneous injection, weekly |
| Prescription required | No | Yes |
| Insurance coverage | No | Sometimes, with prior authorization and BMI/comorbidity criteria |
| Typical out-of-pocket cost | ~$2–4 per day on quarterly subscription | ~$1,300 per month list price (often lower with insurance or savings card) |
| Common side effects | Mild skin irritation at patch site | Nausea, vomiting, constipation, diarrhea, fatigue |
| Serious side effects | Rare; mostly skin sensitization | Pancreatitis, gallbladder disease, kidney injury (uncommon but documented) |
| Clinical trial evidence for weight loss | No published RCT for this specific product | STEP 1: ~14.9% body weight loss at 68 weeks |
| Onset of appetite effect | Often around 10–14 days in user reports | Typically within first 2–4 weeks of dose escalation |
| Who can use it | Adults without adhesive allergy or major drug interactions | Adults with BMI ≥ 30, or ≥ 27 with weight-related comorbidity |
| Discontinuation effect | Effect appears to fade gradually over weeks | Weight regain is well-documented after stopping |
Where I am coming from
I am Linda Halberg, a 62-year-old retired teacher in Columbus, Ohio. I started Wegovy in October 2023 at the recommendation of my endocrinologist after gaining nineteen pounds in the two years following menopause. I came off it in March 2024 because the nausea did not lift and my insurance refused to renew coverage. I tried Mounjaro briefly in late 2024 with similar tolerability problems. In February 2025 I started Ledisa, the botanical patch, after my sister had a good experience with it. My full 90-day Ledisa review covers that experiment in detail.
This comparison page exists because the question "is Ledisa as good as Wegovy" is the wrong question. They are different categories of product, with different mechanisms, different evidence bases, and different roles in a realistic weight-management plan. The right question is: which of these is the right tool for your specific situation, given your tolerance, your access, and your budget.
How they work
Wegovy: a peptide mimetic, weekly injection
Wegovy is the brand name for semaglutide 2.4 mg, a synthetic version of GLP-1, a hormone the gut releases after eating. It slows gastric emptying, increases satiety signals to the brain, and reduces food reward. The STEP 1 trial, published in the New England Journal of Medicine in 2021, showed an average 14.9% reduction in body weight over 68 weeks compared to 2.4% on placebo. The dropout rate due to adverse events was around 7%.
Subjectively, for me, Wegovy quieted hunger more completely than anything I have ever experienced. I forgot I had a body for whole afternoons. The trouble was that the nausea quieted everything else too, including the desire to eat enough to stay healthy.
Ledisa: botanical compounds, daily transdermal patch
Ledisa contains a stack of botanical compounds delivered through the skin. The most evidence-backed ingredient is berberine, an alkaloid from the barberry plant. Oral berberine has been compared to metformin in human trials of type 2 diabetes; see Yin et al., 2012 for an early comparison study. Cinnamon bark extract, green tea catechins, apple cider vinegar, and chromium picolinate round out the formula.
The proposed mechanism is not GLP-1 mimicry. It is a small downward nudge on appetite and post-meal glucose spikes, layered onto whatever the user is already doing. There is no published randomized controlled trial of the Ledisa formulation specifically. There is meaningful research on the individual ingredients at oral doses, and limited research on transdermal absorption of these specific compounds.
Effect size: the unavoidable honest comparison
Wegovy produced 12 pounds of weight loss for me in six weeks before the nausea forced me off. That is an aggressive trajectory and not what the trial average looks like — the trial average is roughly a pound a week sustained over more than a year.
Ledisa produced 10.8 pounds of weight loss for me in 90 days. The trajectory was steadier, the floor was lower, and I was still on the product at the end with the option to continue. I cannot tell you what month six or month twelve looks like because I am not there yet.
If you held a gun to my head and made me pick which drug delivers more weight loss in a healthy person who tolerates it: Wegovy, by a clear margin. If you let me ask one more question — "and which drug can the patient actually stay on?" — the answer becomes specific to that patient. For me, Wegovy was theoretically more effective and practically unusable. The patch is theoretically more modest and practically the one I am still on.
If you want to see the product itself, you can see the current Ledisa pricing and subscription terms.
Side effects and tolerability
This is the dimension where the two are most different.
Wegovy: Nausea, vomiting, constipation, diarrhea, fatigue, headache. The trial reported gastrointestinal adverse events in roughly 74% of the semaglutide arm. Most are mild to moderate. A smaller number of patients develop pancreatitis or gallbladder issues; both are listed on the FDA label. The newer ongoing concern about muscle loss and bone density on long-term GLP-1 therapy is a live research area. The FDA's postmarket drug safety page is the right place to monitor evolving labeling.
Ledisa: The dominant side effect is mild skin irritation at the patch site. I had two episodes in 90 days, both mild, both cleared with site rotation. Some users with sensitive skin report more substantial contact dermatitis. Berberine itself, at oral doses, can cause mild gastrointestinal upset; whether the transdermal dose in the patch reaches a level that does this is unclear. I did not experience it.
No comparison is fair if it does not mention this: the worst Wegovy day I had was meaningfully worse than the worst patch day I have had. By an order of magnitude.
Cost
Wegovy's list price in 2026 is in the neighborhood of $1,350 per month in the United States, with significant variation by pharmacy and savings program. With commercial insurance and a manufacturer savings card, some patients pay closer to $25 per month; without, the full price is rarely manageable long-term.
Ledisa's three-month bundle works out to roughly $2 to $4 per day depending on the bundle. The longer commitments (six months) drop the per-day cost further. There is no insurance pathway because it is a supplement.
If a typical year of use is the unit of comparison: Wegovy without insurance is somewhere north of $15,000 a year; Wegovy with insurance is highly variable; Ledisa is in the low four figures. This is not a like-for-like comparison because the products are not equivalent — but cost is a real constraint that shapes which option is actually available to the patient.
Who I think each is for
Wegovy is the right tool if: you meet the BMI criteria, you have insurance coverage or can absorb the cash price, your doctor concurs, and you have either tolerated GLP-1 drugs before or are willing to ride out the titration phase. The evidence base for sustained weight loss is the strongest in this category.
Ledisa is the right tool if: you do not qualify, cannot afford, or cannot tolerate a prescription GLP-1; you want a low-friction daily tool that nudges appetite rather than replacing your decision-making; you have intact skin and no major adhesive allergy; you are willing to read the auto-renewal terms on the subscription; and you are realistic that a botanical patch is not a miracle.
These are not the only two options. Metformin (off-label), bupropion-naltrexone (Contrave), tirzepatide (Zepbound, the chemical sibling of Mounjaro), and pure-behavior interventions like a registered dietitian and a walking habit are all in the same decision space. This page is just about the two products in the title.
The honest verdict
Wegovy is the more powerful product. Ledisa is the more sustainable one for the specific subset of people — me included — who could not stay on Wegovy. They are not in competition. They are tools on different shelves, and which one belongs in your hand depends on questions that no review site can answer for you: how does your body tolerate semaglutide, what does your insurance cover, how much weight do you actually need to lose, and what is your honest budget.
If you want the full context on my own experience, read my 90-day Ledisa review. If you are weighing whether the patch is real at all, the does-it-actually-work page deals with that head-on. The ingredients page covers the research on each compound separately.
Frequently asked questions
Is Ledisa a replacement for Wegovy?
No. Wegovy is a prescription GLP-1 receptor agonist (semaglutide) approved for chronic weight management. Ledisa is a botanical patch containing berberine, cinnamon, green tea, apple cider vinegar, and chromium. The mechanisms are not equivalent and the clinical evidence base is incomparable. Ledisa is best understood as a lower-cost natural alternative for people who could not tolerate Wegovy or do not have access to it.
How does the weight loss on Ledisa compare to Wegovy?
In the STEP 1 trial, average weight loss on semaglutide 2.4 mg over 68 weeks was roughly 14.9% of body weight. There is no comparable clinical trial for Ledisa. In my own 90 days I lost roughly 5.8% of body weight. The drug is more powerful by a large margin. The patch is meaningfully less powerful, meaningfully less expensive, and meaningfully less tolerable for me personally — I could not stay on Wegovy past six weeks.
Does Ledisa have the same side effects as Wegovy?
No. Wegovy commonly causes nausea, vomiting, constipation or diarrhea, and a smaller number of more serious adverse effects including pancreatitis and gallbladder issues. Ledisa's most common side effect is mild skin irritation at the patch site. The two products do not share a mechanism and do not share a side-effect profile.
Can you take Ledisa and Wegovy at the same time?
You should not do this without a conversation with the prescriber of your Wegovy. Berberine in Ledisa interacts with blood sugar medications and can compound the blood-glucose effects of GLP-1 drugs. The decision is medical, not editorial.
Why would someone choose Ledisa over Wegovy?
Cost (a few hundred dollars per quarter versus over a thousand dollars per month for Wegovy without insurance), accessibility (no prescription, no clinic visit, no eligibility screening), and tolerability (no nausea, no injection). The trade-off is a meaningfully smaller effect size on weight.
Is Wegovy still the gold standard for weight loss?
For people who meet the clinical criteria and can tolerate it, yes — the trial data is strong. The honest framing is that Wegovy and Ledisa serve different populations. Wegovy is for people who qualify, can afford it, and can tolerate it. Ledisa exists for the substantial group of people who fall outside one or more of those conditions.
Can you use Ledisa after stopping Wegovy?
This is the situation I was in. I came off Wegovy in March 2024 due to nausea and insurance, gained eight of twelve pounds back over four months, and started Ledisa in February 2025. There is no clinical research on this exact transition. My personal experience was that the patch helped me stabilize and reverse the post-Wegovy weight regain. Your experience may not match.
Does insurance cover Ledisa?
No. Ledisa is a dietary supplement and is not covered by health insurance. Wegovy may be covered, depending on your insurer and indication, but coverage is increasingly restricted and prior authorizations are common.